03886.HK
Town Health International Medical Group Limited
HKSE · Healthcare · Medical - Care Facilities · HK
HKD 0.18
−0.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.6B | 1.8B | 1.8B | 1.8B | 1.5B |
| Cost of Revenue | 2.8B | 1.4B | 1.3B | 1.3B | 1.1B |
| Gross Profit | 810.7M | 347.7M | 487.4M | 501.9M | 414.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 712.6M | 385.4M | 396.8M | 396.2M | 398.0M |
| General & Admin Expense | 394.6M | 385.4M | 396.8M | 396.2M | 398.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (51.4M) | (116.5M) | — | 3.3M | (113.8M) |
| Total Operating Expenses | 661.2M | 268.9M | 396.8M | 399.5M | 284.1M |
| Cost and Expenses | 3.4B | 1.7B | 1.7B | 1.7B | 1.5B |
| Operating Income (EBIT) | 149.5M | 78.8M | 90.6M | 102.4M | 15.3M |
| Non-Operating | |||||
| Interest Income | 64.8M | 32.4M | 33.2M | 31.7M | 29.5M |
| Interest Expense | 24.1M | 11.5M | 20.5M | 23.4M | 12.7M |
| Net Interest Income | 40.7M | 20.9M | 12.7M | 8.3M | 16.8M |
| Other Non-Op Income/Expense | (103.7M) | 26.2M | (205.2M) | (223.3M) | 67.2M |
| Non-Operating Income (excl Interest) | — | — | 121.3M | 194.6M | — |
| EBT (Pre-Tax Income) | 45.9M | 105.0M | (114.5M) | (120.9M) | 82.5M |
| Income Tax Expense | 73.5M | 40.2M | 36.5M | 38.2M | 33.0M |
| Bottom Line | |||||
| Net Income | (128.7M) | 14.4M | (203.7M) | (194.2M) | 15.3M |
| Earnings from Cont. Ops | (27.6M) | 64.8M | (158.2M) | (159.1M) | 49.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (128.7M) | 14.4M | (203.7M) | (194.2M) | 15.3M |
| Per Share | |||||
| Basic EPS | (HK$0.02) | HK$0.00 | (HK$0.03) | (HK$0.03) | HK$0.00 |
| Diluted EPS | (HK$0.02) | HK$0.00 | (HK$0.03) | (HK$0.03) | HK$0.00 |
| Revenue Per Share | HK$0.53 | HK$0.26 | HK$0.27 | HK$0.27 | HK$0.21 |
| Shares | |||||
| Basic Shares Outstanding | 6.8B | 6.8B | 6.8B | 6.8B | 7.3B |
| Diluted Shares Outstanding | 6.8B | 6.8B | 6.8B | 6.8B | 7.3B |
| Profitability Metrics | |||||
| EBITDA | 375.7M | 210.1M | 160.7M | 53.5M | 237.6M |
| D&A | 226.2M | 131.4M | 70.1M | 145.6M | 127.6M |
| EBIT | 149.5M | 78.8M | 90.6M | (92.1M) | 110.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026